Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Hanna J. Garzozi"'
Autor:
Oren Tomkins, Hanna J Garzozi
Publikováno v:
Clinical Ophthalmology, Vol 2008, Iss Issue 4, Pp 863-867 (2008)
Oren Tomkins, Hanna J GarzoziDepartment of Ophthalmology, Bnai Zion Medical Center, Haifa, IsraelAbstract: Corneal ectasia, a weakening of corneal integrity, occurs both due to acquired and congenital conditions such as keratoconus. It is a progressi
Externí odkaz:
https://doaj.org/article/6b93b4dd05fd4735888c2ed33e03d1c8
Publikováno v:
International Journal of Keratoconus and Ectatic Corneal Diseases. 7:121-127
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22a2649062b13560a8410534b39887e2
https://doi.org/10.5005/jp-journals-10025-1168
https://doi.org/10.5005/jp-journals-10025-1168
Publikováno v:
Ophthalmologica. Jun2006, Vol. 220 Issue 4, p242-245. 4p.
Publikováno v:
International Journal of Keratoconus and Ectatic Corneal Diseases. 1:57-60
Purpose To evaluate the efficacy of corneal cross-linking on keratoconic eyes in the pediatric age group. Setting Private laser center, Haifa, Israel, affiliated to Hadassah Hospital, Jerusalem. Methods This is a retrospective study of 29 eyes of 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::438f6d78787bf2387ab72e71ee6794c3
https://doi.org/10.5005/jp-journals-10025-1010
https://doi.org/10.5005/jp-journals-10025-1010
Publikováno v:
International Journal of Keratoconus and Ectatic Corneal Diseases. 1:109-116
Purpose To evaluate the efficacy of the combined treatment of Intacs SK (Severe keratoconus) and corneal collagen cross- linking in the management of advanced keratoconus (KC). Setting Private laser center, Haifa, Israel. Affiliated to Hadassah Hospi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a41dd3d8ec6d013a97aa8b65b549016
https://doi.org/10.5005/jp-journals-10025-1020
https://doi.org/10.5005/jp-journals-10025-1020
Publikováno v:
International Journal of Keratoconus and Ectatic Corneal Diseases. 1:134-139
Corneal cross-linking has proven safety and efficacy in arresting the progression of keratoconus. Its use has been extended to resolution of corneal edema. We present a case report and review of literature on the treatment of corneal edema using corn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0948736d0f6305836b7b1c3d92da201d
https://doi.org/10.5005/jp-journals-10025-1026
https://doi.org/10.5005/jp-journals-10025-1026
Autor:
David Zadok, Hanna J. Garzozi, Joseph Pikkel, Lamis Abdelaziz, Orwa Nasser, Arie L. Marcovich
Publikováno v:
International Journal of Keratoconus and Ectatic Corneal Diseases. 1:68-72
Collagen corneal cross-linking (CXL) has proved to be effective in halting the progression of keratoconus and post-LASIK ectasia. Post-photorefractive keratectomy (PRK) ectasia, a rare PRK complication, has been reported in only a few cases, although
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ed4a12a890d51aa79b4420826822c34
https://doi.org/10.5005/jp-journals-10025-1013
https://doi.org/10.5005/jp-journals-10025-1013
Publikováno v:
International Journal of Keratoconus and Ectatic Corneal Diseases. 1:190-195
Post-Lasik ectasia is the most feared complication following laser in situ keratomileusis (Lasik), occurring in majority of cases within 1 year of surgery. Furthermore, it is reported many years after surgery. In this case series, we report on late o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8502de917c55a14ecdb6aabd0d830a9
https://doi.org/10.5005/jp-journals-10025-1036
https://doi.org/10.5005/jp-journals-10025-1036
Publikováno v:
International Journal of Keratoconus and Ectatic Corneal Diseases. 1:179-184
Collagen corneal cross-linking is an acceptable method for halting the progression of keratoconus and post-Lasik ectasia. The traditional method advocates the removal of epithelium for proper saturation of riboflavin within the stroma. The postoperat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56001cf7bd800ca07eee160f3cc0dbf6
https://doi.org/10.5005/jp-journals-10025-1034
https://doi.org/10.5005/jp-journals-10025-1034
Autor:
Noa Chetrit, Pnina Fishman, William D Kerns, Kenneth A. Jacobson, Irina S. Barequet, Motti Farbstein, Sara Bar Yehuda, Hanna J. Garzozi, Gil Sartani, Michael H. Silverman, Gilad Litvin, Erez Bakshi, Oren Tomkins, David Zadok, Ilan Cohn, Zivit Harpaz, Fanni Segev, David Bristol, Sari Fishman, David Varssano, Isaac Avni
Publikováno v:
Ophthalmology. 117:1287-1293
Objective To explore the safety and efficacy of CF101, an A 3 adenosine receptor agonist, in patients with moderate to severe dry eye syndrome. Design Phase 2, multicenter, randomized, double-masked, placebo-controlled, parallel-group study. Particip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::892ce353f39cb2ceabc184845b3441f6
https://doi.org/10.1016/j.ophtha.2009.11.029
https://doi.org/10.1016/j.ophtha.2009.11.029